Divergent Obesity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model
Authors' conclusion
EOSS and DMO provide complementary approaches to obesity classification, with differing classification patterns highlighting distinct concepts of obesity-related disease severity.
Study context
- Population
- UK Biobank participantsUK Biobank
- Participants
- ≈ 411,000 participants
- Exposure
- Edmonton Obesity Staging System (EOSS) vs Lancet Commission Diagnostic Model for Obesity (DMO) obesity classification
- Outcome
- Classification patterns and concordance of EOSS and DMO
Methodological detailspopulation-based cohort
- Population-based cohort
Main finding
As reported in the abstract
- About one-quarter of participants classified with obesity under both frameworks
- Most assigned to advanced stages, with high concordance for established disease
- Differences most pronounced in early stages: DMO captured broader spectrum of mild/subclinical organ dysfunction; EOSS emphasized more advanced obesity-related disease
- Discrepancies reflected differing operationalization of e.g. metabolic, CVD and mental health domains
Observational data: associations, not effects.
Further findings
Reclassification when BMI combined with fat distribution parameters
- Reclassified when BMI combined with different fat distribution parameters
- ≈50%
Original publication
Divergent Obesity Classification Between the Edmonton Obesity Staging System and the Lancet Commission Model. Obesity (Silver Spring). Published 1 September 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →